2024-04-23 16:23 | CC:CTX | Crescita Therapeutics Inc | 0.44 | SEDAR Annual Report803 | SEDAR Annual Report |
2024-03-26 12:37 | CC:CTX | Crescita Therapeutics Inc | 0.43 | SEDAR Annual Information Form802 | SEDAR Annual Information Form |
2024-03-13 10:52 | CC:CTX | Crescita Therapeutics Inc | 0.375 | News Release200 | Crescita Therapeutics loses $1.98-million in FY 2023 |
2024-03-13 08:10 | CC:CTX | Crescita Therapeutics Inc | 0.375 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2024-03-13 08:10 | CC:CTX | Crescita Therapeutics Inc | 0.375 | SEDAR MD & A815 | SEDAR MD & A |
2023-11-08 14:00 | CC:CTX | Crescita Therapeutics Inc | 0.45 | News Release200 | Crescita Therapeutics loses $1.28-million in Q3 |
2023-11-08 08:05 | CC:CTX | Crescita Therapeutics Inc | 0.61 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-11-08 08:05 | CC:CTX | Crescita Therapeutics Inc | 0.61 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-08-29 13:03 | CC:CTX | Crescita Therapeutics Inc | 0.66 | News Release200 | Crescita to buy back up to 1.82 million shares |
2023-08-09 12:53 | CC:CTX | Crescita Therapeutics Inc | 0.73 | News Release200 | Crescita Therapeutics loses $281,000 in Q2 2023 |
2023-08-09 08:16 | CC:CTX | Crescita Therapeutics Inc | 0.73 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-06-21 10:59 | CC:CTX | Crescita Therapeutics Inc | 0.65 | News Release200 | Crescita shareholders elect five directors at AGSM |
2023-06-01 09:46 | CC:CTX | Crescita Therapeutics Inc | 0.66 | News Release200 | Crescita, Croma sign Pliaglis licence agreement |
2023-05-11 14:12 | CC:CTX | Crescita Therapeutics Inc | 0.65 | News Release200 | Crescita Therapeutics loses $273,000 in Q1 2023 |
2023-05-11 08:05 | CC:CTX | Crescita Therapeutics Inc | 0.65 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-05-11 08:05 | CC:CTX | Crescita Therapeutics Inc | 0.65 | SEDAR MD & A815 | SEDAR MD & A |